Terms: = Endocrine gland cancer AND NFE2L2, ENSG00000116044, 4780, Q16236, NRF2 AND Prognosis
26 results:
1. Targeting nrf2 to treat thyroid cancer.
Gong Z; Xue L; Li H; Fan S; van Hasselt CA; Li D; Zeng X; Tong MCF; Chen GG
Biomed Pharmacother; 2024 Apr; 173():116324. PubMed ID: 38422655
[TBL] [Abstract] [Full Text] [Related]
2. Brusatol attenuated proliferation and invasion induced by KRAS in differentiated thyroid cancer through inhibiting nrf2.
Gong Z; Xue L; Vlantis AC; van Hasselt CA; Chan JYK; Fang J; Wang R; Yang Y; Li D; Zeng X; Tong MCF; Chen GG
J Endocrinol Invest; 2024 May; 47(5):1271-1280. PubMed ID: 38062319
[TBL] [Abstract] [Full Text] [Related]
3. SLC38A5 Modulates Ferroptosis to Overcome Gemcitabine Resistance in Pancreatic cancer.
Kim MJ; Kim HS; Kang HW; Lee DE; Hong WC; Kim JH; Kim M; Cheong JH; Kim HJ; Park JS
Cells; 2023 Oct; 12(20):. PubMed ID: 37887353
[TBL] [Abstract] [Full Text] [Related]
4. STAT3 inhibition enhances gemcitabine sensitivity in pancreatic cancer by suppressing EMT, immune escape and inducing oxidative stress damage.
Guo H; Hu Z; Yang X; Yuan Z; Gao Y; Chen J; Xie L; Chen C; Guo Y; Bai Y
Int Immunopharmacol; 2023 Oct; 123():110709. PubMed ID: 37515849
[TBL] [Abstract] [Full Text] [Related]
5. UBE2E2 enhances Snail-mediated epithelial-mesenchymal transition and nrf2-mediated antioxidant activity in ovarian cancer.
Hong X; Ma N; Li D; Zhang M; Dong W; Huang J; Ci X; Zhang S
Cell Death Dis; 2023 Feb; 14(2):100. PubMed ID: 36765041
[TBL] [Abstract] [Full Text] [Related]
6. Cinchonine-induced cell death in pancreatic cancer cells by downregulating RRP15.
Liang F; Lv Y; Qiao X; Zhang S; Shen S; Wang C; Xu G; Zou X; Wang L; Zhang B
Cell Biol Int; 2023 May; 47(5):907-919. PubMed ID: 36682038
[TBL] [Abstract] [Full Text] [Related]
7. Brucein D augments the chemosensitivity of gemcitabine in pancreatic cancer via inhibiting the nrf2 pathway.
Zhang J; Xu HX; Cho WCS; Cheuk W; Li Y; Huang QH; Yang W; Xian YF; Lin ZX
J Exp Clin Cancer Res; 2022 Mar; 41(1):90. PubMed ID: 35272669
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic Value and Immune Infiltration Analysis of Nuclear Factor Erythroid-2 Family Members in Ovarian cancer.
Dou R; Wang X; Zhang J
Biomed Res Int; 2022; 2022():8672258. PubMed ID: 35059466
[TBL] [Abstract] [Full Text] [Related]
9. Diosmetin induces apoptosis in ovarian cancer cells by activating reactive oxygen species and inhibiting the nrf2 pathway.
Zhao F; Hong X; Li D; Wei Z; Ci X; Zhang S
Med Oncol; 2021 Apr; 38(5):54. PubMed ID: 33811596
[TBL] [Abstract] [Full Text] [Related]
10. MGST1 is a redox-sensitive repressor of ferroptosis in pancreatic cancer cells.
Kuang F; Liu J; Xie Y; Tang D; Kang R
Cell Chem Biol; 2021 Jun; 28(6):765-775.e5. PubMed ID: 33539732
[TBL] [Abstract] [Full Text] [Related]
11. Undermining Glutaminolysis Bolsters Chemotherapy While nrf2 Promotes Chemoresistance in KRAS-Driven Pancreatic cancers.
Mukhopadhyay S; Goswami D; Adiseshaiah PP; Burgan W; Yi M; Guerin TM; Kozlov SV; Nissley DV; McCormick F
Cancer Res; 2020 Apr; 80(8):1630-1643. PubMed ID: 31911550
[TBL] [Abstract] [Full Text] [Related]
12. HEATR1 deficiency promotes pancreatic cancer proliferation and gemcitabine resistance by up-regulating nrf2 signaling.
Zhou Y; Wang K; Zhou Y; Li T; Yang M; Wang R; Chen Y; Cao M; Hu R
Redox Biol; 2020 Jan; 29():101390. PubMed ID: 31785531
[TBL] [Abstract] [Full Text] [Related]
13. NO
Wang L; Tang W; Yang S; He P; Wang J; Gaedcke J; Ströbel P; Azizian A; Ried T; Gaida MM; Yfantis HG; Lee DH; Lal A; Van den Eynde BJ; Alexander HR; Ghadimi BM; Hanna N; Hussain SP
Int J Cancer; 2020 Jun; 146(11):3160-3169. PubMed ID: 31609478
[TBL] [Abstract] [Full Text] [Related]
14. nrf2 induced cisplatin resistance in ovarian cancer by promoting CD99 expression.
Wu J; Zhang L; Li H; Wu S; Liu Z
Biochem Biophys Res Commun; 2019 Oct; 518(4):698-705. PubMed ID: 31472965
[TBL] [Abstract] [Full Text] [Related]
15. PIN1 Maintains Redox Balance via the c-Myc/nrf2 Axis to Counteract Kras-Induced Mitochondrial Respiratory Injury in Pancreatic cancer Cells.
Liang C; Shi S; Liu M; Qin Y; Meng Q; Hua J; Ji S; Zhang Y; Yang J; Xu J; Ni Q; Li M; Yu X
Cancer Res; 2019 Jan; 79(1):133-145. PubMed ID: 30355620
[TBL] [Abstract] [Full Text] [Related]
16. GRP78-mediated antioxidant response and ABC transporter activity confers chemoresistance to pancreatic cancer cells.
Dauer P; Sharma NS; Gupta VK; Nomura A; Dudeja V; Saluja A; Banerjee S
Mol Oncol; 2018 Sep; 12(9):1498-1512. PubMed ID: 29738634
[TBL] [Abstract] [Full Text] [Related]
17. Expression Patterns of nrf2 and Keap1 in Ovarian cancer Cells and their Prognostic Role in Disease Recurrence and Patient Survival.
Cho HY; Kim K; Kim YB; Kim H; No JH
Int J Gynecol Cancer; 2017 Mar; 27(3):412-419. PubMed ID: 28129239
[TBL] [Abstract] [Full Text] [Related]
18. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/nrf2 pathway in pancreatic cancer cells.
Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
[TBL] [Abstract] [Full Text] [Related]
19. ALDOA functions as an oncogene in the highly metastatic pancreatic cancer.
Ji S; Zhang B; Liu J; Qin Y; Liang C; Shi S; Jin K; Liang D; Xu W; Xu H; Wang W; Wu C; Liu L; Liu C; Xu J; Ni Q; Yu X
Cancer Lett; 2016 Apr; 374(1):127-135. PubMed ID: 26854714
[TBL] [Abstract] [Full Text] [Related]
20. BRCA1 deficiency increases the sensitivity of ovarian cancer cells to auranofin.
Oommen D; Yiannakis D; Jha AN
Mutat Res; 2016; 784-785():8-15. PubMed ID: 26731315
[TBL] [Abstract] [Full Text] [Related]
[Next]
